Marker Therapeutics Stock (NASDAQ:MRKR), Quotes and News Summary

Q: What sector and industry does Marker Therapeutics (MRKR) operate in?

Marker Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Marker Therapeutics Stock (NASDAQ: MRKR) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 19.808K
Day Range	- - -
52 Wk Range	0.760 - 9.680
Market Cap	$37.837M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	1.69%
Days to Cover	5.06

Recent News

Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization

Marker Therapeutics Inc (NASDAQ: MRKR) announced it is restructuring its clinical programs and strategic prioritization of its multi-tumor associated antigen (multiTAA)-specific T cell product pipeline.

Vandana Singh

Why Is Blood Cancer Focused Marker Therapeutics Stock Trading Higher Today?

Marker Therapeutics Inc (NASDAQ: MRKR) released the preliminary results of the first participant treated with MT-601, its multi-tumor associated antigen (multiTAA)-specific T cell product targeting 6 TAAs, in the Phase 1 multicenter

Vandana Singh

Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) jumped 76% to $28.13 after the company's once-daily oral paltusotine achieved the primary and secondary endpoints in the Phase 3 PATHFNDR-1 study in acromegaly.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

3.0

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

About Marker Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Marker Therapeutics (MRKR) stock?

You can purchase shares of Marker Therapeutics (NASDAQ: MRKR) through any online brokerage.

View our list of the best stock brokerages.

Who are Marker Therapeutics's (MRKR) competitors?

Other companies in Marker Therapeutics’s space includes: Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX) and Bolt Biotherapeutics (NASDAQ:BOLT).

What is the target price for Marker Therapeutics (MRKR) stock?

The latest price target for Marker Therapeutics (NASDAQ: MRKR) was reported by Roth Capital on Thursday, February 17, 2022. The analyst firm set a price target for 1.00 expecting MRKR to fall to within 12 months (a possible -76.47% downside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Marker Therapeutics (MRKR)?

The stock price for Marker Therapeutics (NASDAQ: MRKR) is $4.25 last updated April 16, 2024 at 4:21 PM EDT.

Does Marker Therapeutics (MRKR) pay a dividend?

There are no upcoming dividends for Marker Therapeutics.

When is Marker Therapeutics (NASDAQ:MRKR) reporting earnings?

Marker Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.

Is Marker Therapeutics (MRKR) going to split?

There is no upcoming split for Marker Therapeutics.

What sector and industry does Marker Therapeutics (MRKR) operate in?

Marker Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-